Effective treatment of Kaposi's sarcoma with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388). [electronic resource]
Producer: 19730710Description: 65-71 p. digitalISSN:- 0069-0112
- Adult
- Amides -- therapeutic use
- Antineoplastic Agents -- adverse effects
- Blood Cell Count
- Dactinomycin -- therapeutic use
- Drug Resistance
- Humans
- Imidazoles -- adverse effects
- Male
- Middle Aged
- Remission, Spontaneous
- Sarcoma, Kaposi -- drug therapy
- Skin Neoplasms -- drug therapy
- Triazenes -- adverse effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.